NEW YORK (Reuters Health) - Taking a statin drug does not seem to increase or decrease the likelihood of a woman developing breast cancer, according to a study published in the medical journal Cancer.
Some lab studies have shown that statins inhibit the proliferation of breast cancer cells, note Dr. Gaia Pocobelli, of the University of Washington, Seattle, and colleagues. Conversely, other studies, in which rodents were exposed to high doses of statins, showed increases in several types of cancer.
To look into the question, the researchers identified 4179 women with invasive breast cancer, randomly selected from population-based cancer registries in Wisconsin, Massachusetts, and New Hampshire. For comparison, 4983 "controls" were also randomly selected in each state, from lists of licensed drivers and Medicare beneficiaries.
Structured telephone interviews were conducted to obtain information on the use of statins and breast cancer risk factors.
Overall, 7.0 percent of all the women had ever taken a statin, including 271 women with breast cancer and 336 of the controls.
The overall use of statins was not associated with breast cancer risk, Dr. Pocobelli and colleagues found. They also observed no relationship between duration of use and cancer risk.
However, given the large number of people taking these drugs, they suggest that further investigation of individual statins is warranted.
SOURCE: Cancer, January 1, 2008.
The study reviewed here found that statins, medicines taken to lower "bad" (LDL) cholesterol, don't affect breast cancer risk. The results agree with other research that looked at how statins affect cancer risk.
Millions of people around the world take statins. These medicines can help people who have high cholesterol and a higher than average risk for heart attack and stroke, including people with diabetes, high blood pressure, or a strong family history of heart disease.
Zocor and Vytorin (chemical name: simvastatin), Pravachol (chemical name: pravastatin), Lipitor (chemical name: atorvastatin), and Crestor (chemical name: rosuvastatin) are all statins. This study looked at breast cancer risk in a large group of women who were all taking different statins. Since each statin is chemically different, more research is needed to study whether each individual statin affects breast cancer risk.
Stay tuned to breastcancer.org for the latest news on breast cancer risk, diagnosis and treatment and how it affects YOU.
Breastcancer.org 7 East Lancaster Avenue, 3rd Floor Ardmore, PA 19003
Learn more about our commmitment to your privacy
© 2008 Breastcancer.org - All rights reserved.
Breastcancer.org is a non-profit organization dedicated to providing information and community to those touched by this disease. Learn more about our commitment to providing complete, accurate, and private breast cancer information.